Immune-Based Stratification of Breast Cancer Reveals Biologically Distinct Tumor Microenvironment Phenotypes with Prognostic Implications
Cancers · 19.11.2026 · 18 (22) · 3699
DOI: 10.3390/cancers18223699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 19.11.2026. Verfasst von Khalil Choukri und 5 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moroccan Ministry of Higher Education, Research, and Innovation, Moroccan Ministry of Higher Education, Research, and Innovation and the Digital Development Agency “ADD”, Intra-Africa Academic Mobility Grant provided by the EUROPEAN COMMISSION.
Abstract (Originalsprache)
Background
Conventional breast cancer molecular classification has improved therapeutic stratification but remains insufficient to capture tumor microenvironment (TME) heterogeneity. Even within aggressive subgroups, such as triple-negative breast cancer (TNBC), substantial immune variability persists without a robust microenvironmental stratification framework. We aimed to define reproducible, immune-based TME phenotypes using transcriptomic profiling and evaluate their biological, prognostic, and immunological relevance.
Methods
Using bulk transcriptomic and clinical data from 1980 primary breast tumors in the METABRIC discovery cohort, relative abundances of 22 immune cell populations were estimated via CIBERSORTx, followed by silhouette-guided K-means clustering. Microenvironmental composition and tumor purity were quantified using the ESTIMATE algorithm, while differential gene expression (DGE) and gene set enrichment analysis (GSEA) characterized underlying transcriptional programs. Prognostic independence was evaluated using Kaplan–Meier and multivariable Cox proportional hazards models, and immune-evasion mechanics alongside predicted checkpoint blockade sensitivity were estimated using the Tumor Immune Dysfunction and Exclusion (TIDE) framework. Phenotypic reproducibility was evaluated via nearest-centroid projection in an independent TCGA-BRCA validation cohort (n = 1070).
Results
Three distinct immune-based TME phenotypes (Clusters 1–3) were identified across conventional PAM50 molecular subtypes. Cluster 1 (immune-excluded-like) exhibited the highest tumor purity, reduced immune scores, enrichment of extracellular matrix and epithelial programs, elevated T cell exclusion scores, and the poorest overall survival, remaining an independent predictor of mortality after adjusting for age, histologic grade, and molecular subtype (multivariable HR = 1.21, 95% CI: 1.04–1.40, p = 0.013). Cluster 2 (immune-inflamed-like) displayed elevated immune and ESTIMATE scores, enrichment of interferon-γ, antigen presentation, and cytotoxic T cell signaling, and the lowest composite TIDE scores (adjusted p ≤ 0.0001 vs. Clusters 1 and 3), driven by elevated T cell dysfunction rather than exclusion. Cluster 3 (stromal-rich/immune-modulated) demonstrated the highest stromal scores alongside estrogen-responsive, adipogenic, and TGF-β-associated signatures, and shared elevated T cell exclusion with Cluster 1. Nearest-centroid projection in TCGA-BRCA reproduced these cellular and transcriptional profiles.
Conclusions
Immune-based clustering uncovers a reproducible dimension of breast cancer biology that cuts across intrinsic molecular subtypes and provides independent prognostic stratification in the discovery cohort. While these transcriptomic and TIDE profiles generate the hypothesis that immune-inflamed tumors may be more amenable to immune checkpoint blockade whereas excluded or stromal-rich phenotypes may require microenvironment-modulating strategies, prospective clinical validation is required before clinical implementation.
Förderung
- Moroccan Ministry of Higher Education, Research, and Innovation
- Moroccan Ministry of Higher Education, Research, and Innovation and the Digital Development Agency “ADD”
- Intra-Africa Academic Mobility Grant provided by the EUROPEAN COMMISSION
Zitieren
APA
Choukri, K., Souaf, D., Jannane, S., Baddi, H., Zanzoum, I., & Badou, A. (2026). Immune-Based Stratification of Breast Cancer Reveals Biologically Distinct Tumor Microenvironment Phenotypes with Prognostic Implications. Cancers, 18(22), 3699. https://doi.org/10.3390/cancers18223699
Vancouver
Choukri K, Souaf D, Jannane S, Baddi H, Zanzoum I, Badou A. Immune-Based Stratification of Breast Cancer Reveals Biologically Distinct Tumor Microenvironment Phenotypes with Prognostic Implications. Cancers. 2026;18(22):3699. doi:10.3390/cancers18223699
BibTeX
@article{Choukri2026,
author = {Choukri, Khalil and Souaf, Dounia and Jannane, Salma and Baddi, Hamza and Zanzoum, Ilham and Badou, Abdallah},
title = {Immune-Based Stratification of Breast Cancer Reveals Biologically Distinct Tumor Microenvironment Phenotypes with Prognostic Implications},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3699},
doi = {10.3390/cancers18223699}
}
EUVIMED